Christopher Bird Announced as New Chief Medical Officer of BioPorto

The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer.

Bird joins BioPorto from his role at Roche Diagnostics as Head of Medical and Scientific Affairs in North America. After over 10 years with this medical and scientific affairs organisation, Christopher will now be responsible for leading the development of diagnostic products at BioPorto.

Image Credit: Proactive Investors

Published on : Mon, 1 Jul 2019

BioPorto, Roche, Chief Medical Officer, Christopher Bird, Roche Diagnostics, Medical and Scientific Affairs, Head of Medical and Scientific Affairs, Bird, Christopher, medical diagnostic

BioPorto, Roche, Chief Medical Officer, Christopher Bird, Roche Diagnostics, Medical and Scientific Affairs, Head of Medical and Scientific Affairs, Bird, Christopher, medical diagnostic The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer.

Christopher Bird Announced as New Chief Medical Officer of BioPorto

No comment

Highlighted Products

Mini-Spike® 2 Chemo
Vented dispensing pin with swabable needlefree access valve (0,2µm air filter and 5µm particle filter).

HAMILTON-MR1 Ventilator: Intelligent Ventilation from ICU to MRI

Caresite®
Luer activated valve developed as needlefree injection port in IV applications

HAMILTON-T1 Ventilator : Intelligent transport ventilation

Intrapur® Plus
0.2 µm infusion filter with positively charged membrane

Industry

Events Calendar

Movers & Shakers